• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Human Hepatocellular Carcinoma (HCC).人类肝细胞癌（HCC）
Cancers (Basel). 2020 Dec 12;12(12):3739. doi: 10.3390/cancers12123739.
2
Cellular prognostic markers in hepatitis-related hepatocellular carcinoma.肝炎相关肝细胞癌的细胞预后标志物
Infect Agent Cancer. 2018 Mar 27;13:10. doi: 10.1186/s13027-018-0183-8. eCollection 2018.
3
[Selective deposition of agrin in the microvasculature of hepatocellular carcinoma: aspects in pathogenesis and differential diagnosis].[硫酸乙酰肝素蛋白聚糖在肝细胞癌微血管中的选择性沉积：发病机制及鉴别诊断方面]
Magy Onkol. 2008 Dec;52(4):379-83. doi: 10.1556/MOnkol.52.2008.4.7.
4
Antiviral therapy and primary and secondary prevention of hepatocellular carcinoma.抗病毒治疗与肝细胞癌的一级和二级预防。
Hepatol Res. 2007 Sep;37 Suppl 2:S294-8. doi: 10.1111/j.1872-034X.2007.00200.x.
5
Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma.启动子区域高甲基化沉默 HOXD10 激活肝癌中的 ERK 信号通路。
Clin Epigenetics. 2017 Oct 23;9:116. doi: 10.1186/s13148-017-0412-9. eCollection 2017.
6
Human hepatocellular carcinoma: expression profiles-based molecular interpretations and clinical applications.人类肝细胞癌：基于表达谱的分子解读与临床应用
Cancer Lett. 2009 Dec 1;286(1):96-102. doi: 10.1016/j.canlet.2008.11.005. Epub 2008 Dec 17.
7
Familial hepatocellular carcinoma: 'A model for studying preventive and therapeutic measures'.家族性肝细胞癌：“一种用于研究预防和治疗措施的模型”
Ann Med Surg (Lond). 2018 Sep 28;35:129-132. doi: 10.1016/j.amsu.2018.09.035. eCollection 2018 Nov.
8
Hepatocellular carcinoma: an epidemiologic view.肝细胞癌：流行病学视角
J Clin Gastroenterol. 2002 Nov-Dec;35(5 Suppl 2):S72-8. doi: 10.1097/00004836-200211002-00002.
9
Glutathione S-Transferase P1 Polymorphism on Exon 6 and Risk of Hepatocellular Carcinoma in Thai Male Patients.谷胱甘肽 S-转移酶 P1 外显子 6 多态性与泰国男性肝细胞癌风险。
Oncology. 2020;98(4):243-247. doi: 10.1159/000505213. Epub 2020 Jan 20.
10
Novel biomarkers in hepatocellular carcinoma.肝细胞癌的新型生物标志物。
Dig Liver Dis. 2018 Nov;50(11):1115-1123. doi: 10.1016/j.dld.2018.08.019. Epub 2018 Aug 24.

引用本文的文献

1
C12ORF49 inhibits ferroptosis in hepatocellular carcinoma cells via reprogramming SREBP1/SCD1-mediated lipid metabolism.C12ORF49通过重编程SREBP1/SCD1介导的脂质代谢抑制肝癌细胞中的铁死亡。
Cell Death Discov. 2025 Apr 16;11(1):178. doi: 10.1038/s41420-025-02480-2.
2
Prognostic analysis of hepatocellular carcinoma with macrovascular invasion after liver resection and a successful case of conversion therapy.肝切除术后伴大血管侵犯的肝细胞癌的预后分析及一例成功的转化治疗病例
Front Surg. 2022 Nov 7;9:1042431. doi: 10.3389/fsurg.2022.1042431. eCollection 2022.
3
An Insight into the Novel Immunotherapy and Targeted Therapeutic Strategies for Hepatocellular Carcinoma and Cholangiocarcinoma.肝细胞癌和胆管癌新型免疫疗法及靶向治疗策略洞察
Life (Basel). 2022 Apr 30;12(5):665. doi: 10.3390/life12050665.

本文引用的文献

1
Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C.慢性丙型肝炎患者使用基于索磷布韦或不含索磷布韦的方案治疗后肝细胞癌的发生率
Cancers (Basel). 2020 Sep 11;12(9):2602. doi: 10.3390/cancers12092602.
2
Radiosensitisation of Hepatocellular Carcinoma Cells by Vandetanib.凡德他尼对肝癌细胞的放射增敏作用
Cancers (Basel). 2020 Jul 13;12(7):1878. doi: 10.3390/cancers12071878.
3
Immune Cytolytic Activity for Comprehensive Understanding of Immune Landscape in Hepatocellular Carcinoma.免疫细胞溶解活性助力全面了解肝细胞癌的免疫格局
Cancers (Basel). 2020 May 13;12(5):1221. doi: 10.3390/cancers12051221.
4
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma.阿替利珠单抗联合贝伐珠单抗治疗不可切除肝细胞癌。
N Engl J Med. 2020 May 14;382(20):1894-1905. doi: 10.1056/NEJMoa1915745.
5
Gene Signature for Sorafenib Susceptibility in Hepatocellular Carcinoma: Different Approach with a Predictive Biomarker.肝细胞癌中索拉非尼敏感性的基因特征：一种具有预测性生物标志物的不同方法。
Liver Cancer. 2020 Apr;9(2):182-192. doi: 10.1159/000504548. Epub 2020 Feb 18.
6
The Crosstalk between Tumor Cells and the Microenvironment in Hepatocellular Carcinoma: The Role of Exosomal microRNAs and their Clinical Implications.肝细胞癌中肿瘤细胞与微环境之间的串扰：外泌体微小RNA的作用及其临床意义
Cancers (Basel). 2020 Mar 29;12(4):823. doi: 10.3390/cancers12040823.
7
Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition.哈普罗利德通过抑制Rb/E2F和Akt/mTOR来抑制肝细胞癌的肿瘤生长。
Cancers (Basel). 2020 Mar 6;12(3):615. doi: 10.3390/cancers12030615.
8
Association of TIM-3 with BCLC Stage, Serum PD-L1 Detection, and Response to Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma.肝细胞癌患者中TIM-3与BCLC分期、血清PD-L1检测及经动脉化疗栓塞反应的相关性
Cancers (Basel). 2020 Jan 15;12(1):212. doi: 10.3390/cancers12010212.
9
Tackling hepatocellular carcinoma with individual or combinatorial immunotherapy approaches.采用个体化或联合免疫治疗方法攻克肝细胞癌。
Cancer Lett. 2020 Mar 31;473:25-32. doi: 10.1016/j.canlet.2019.12.029. Epub 2019 Dec 23.
10
Review article: new therapeutic interventions for advanced hepatocellular carcinoma.综述文章：晚期肝细胞癌的新治疗干预措施。
Aliment Pharmacol Ther. 2020 Jan;51(1):78-89. doi: 10.1111/apt.15573. Epub 2019 Nov 20.

人类肝细胞癌（HCC）

Human Hepatocellular Carcinoma (HCC).

作者信息

Buonaguro Luigi

机构信息

Laboratory of Innovative Immunological Models, Istituto Nazionale per lo Studio e la Cura dei Tumori, "Fondazione Pascale"-IRCCS, 80131 Naples, Italy.

出版信息

Cancers (Basel). 2020 Dec 12;12(12):3739. doi: 10.3390/cancers12123739.

DOI:10.3390/cancers12123739
PMID:33322652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7763211/
Abstract

Hepatocellular carcinoma (HCC) is the fifth most common cancer and accounts for 8 [...].

摘要

肝细胞癌（HCC）是第五大常见癌症，占8 [... ]。